
Cropel Lifesciences Private Limited
This company manufactures and trades pharmaceuticals, healthcare products, and medicinal goods.
This company manufactures and trades pharmaceuticals, healthcare products, and medicinal goods.
Cropel Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 August 2020 (Four years and six months 14 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹2.75 Cr.
Alkesh Sangani, Kishorkumar Kachhadia, Mukeshkumar Vekaria, and Six other members serve as directors at the Company.
Ahmedabad, Gujarat, India
+91-XXXXXXXXXX
-
U24304GJ2020PTC115678
115678
Private Limited Indian Non-Government Company
20 Aug 2020
30 Sep 2024
31 Mar 2024
Unlisted
Roc Ahmedabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mukeshkumar Vekaria ![]() | Director | 29-Mar-2022 | Current |
Alkesh Sangani ![]() | Director | 29-Mar-2022 | Current |
Kishorkumar Kachhadia ![]() | Director | 20-Jul-2022 | Current |
Haresh Tadhani ![]() | Director | 20-Jul-2022 | Current |
Prakash Dobariya ![]() | Director | 29-Mar-2022 | Current |
Jayantilal Bhuva ![]() | Director | 20-Aug-2020 | Current |
Cropel Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1518.14% increase. The company also saw a substantial improvement in profitability, with a 186.29% increase in profit. The company's net worth moved up by a moderate rise of 6.58%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Cropel Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Alkesh Sangani, Mukeshkumar Vekaria and 6 more are mutual person
Mukeshkumar Vekaria, Jaysukhbhai Sangani and 1 more are mutual person
Mukeshkumar Vekaria is a mutual person
Mukeshkumar Vekaria is a mutual person
Jayantilal Bhuva is a mutual person
₹2.75 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
01 Nov 2021 | Indian Bank | ₹2.75 Cr | Open |
Cropel Lifesciences has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cropel Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cropel Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cropel Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Cropel Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Kishorkumar Vallabhbhai Kachhadia was appointed as a Director was appointed as a Director on 20 Jul 2022 & has been associated with this company since 2 years 7 months .
Haresh Vallabhbhai Tadhani was appointed as a Director was appointed as a Director on 20 Jul 2022 & has been associated with this company since 2 years 7 months .
Alkesh Kalubhai Sangani was appointed as a Director was appointed as a Director on 29 Mar 2022 & has been associated with this company since 2 years 11 months .
Mukeshkumar Vallabhbhai Vekaria was appointed as a Director was appointed as a Director on 29 Mar 2022 & has been associated with this company since 2 years 11 months .
Cropel Lifesciences Private Limited was incorporated on 20 Aug 2020.
The authorized share capital of Cropel Lifesciences Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 2.00 Cr.
Currently 9 directors are associated with Cropel Lifesciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cropel Lifesciences Private Limited is 433 G.I.D.C. Odhav Nr. Bhikshuk Gruh, India, Ahmedabd, Gujarat, 382415.
The corporate identification number (CIN) of Cropel Lifesciences Private Limited is U24304GJ2020PTC115678 and the company number is 115678 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Cropel Lifesciences Private Limited has risen by 1518.14%.
The financial reports for the fiscal year 2022 indicates that The net worth of Cropel Lifesciences Private Limited has experienced an upsurge of 6.58%.
As per the financial statements for fiscal Year 2022, The total open charges for Cropel Lifesciences Private Limited amount to ₹ 2.75 Cr.
The most recent Balance Sheet for Cropel Lifesciences Private Limited was filed with the ROC on 31 Mar 2024.